Goldman Sachs Group Inc. raised its stake in Innophos Holdings, Inc. (NASDAQ:IPHS) by 58.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 321,140 shares of the specialty chemicals company’s stock after purchasing an additional 118,043 shares during the quarter. Goldman Sachs Group Inc. owned approximately 1.64% of Innophos Holdings worth $14,079,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of IPHS. Swiss National Bank grew its stake in Innophos Holdings by 2.9% in the first quarter. Swiss National Bank now owns 32,000 shares of the specialty chemicals company’s stock valued at $1,727,000 after purchasing an additional 900 shares in the last quarter. Karp Capital Management Corp bought a new position in Innophos Holdings in the first quarter valued at approximately $346,000. Mason Street Advisors LLC grew its stake in Innophos Holdings by 7.6% in the first quarter. Mason Street Advisors LLC now owns 4,550 shares of the specialty chemicals company’s stock valued at $246,000 after purchasing an additional 321 shares in the last quarter. Prudential Financial Inc. grew its stake in Innophos Holdings by 1.8% in the first quarter. Prudential Financial Inc. now owns 124,191 shares of the specialty chemicals company’s stock valued at $6,703,000 after purchasing an additional 2,240 shares in the last quarter. Finally, Victory Capital Management Inc. bought a new position in Innophos Holdings in the first quarter valued at approximately $535,000. Hedge funds and other institutional investors own 94.26% of the company’s stock.

Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) opened at 49.69 on Tuesday. Innophos Holdings, Inc. has a 12-month low of $39.03 and a 12-month high of $58.22. The firm has a market capitalization of $963.79 million, a PE ratio of 21.70 and a beta of 0.88. The company’s 50-day moving average price is $47.35 and its 200 day moving average price is $45.46.

Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.05. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. The business had revenue of $179.14 million during the quarter, compared to analyst estimates of $172.65 million. During the same period in the prior year, the company earned $0.63 earnings per share. Innophos Holdings’s revenue was down 1.5% compared to the same quarter last year. On average, equities analysts forecast that Innophos Holdings, Inc. will post $2.51 earnings per share for the current year.

A number of research analysts have weighed in on the company. Zacks Investment Research downgraded Innophos Holdings from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 4th. BidaskClub downgraded Innophos Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th.

TRADEMARK VIOLATION WARNING: This story was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/10/17/goldman-sachs-group-inc-has-14-08-million-holdings-in-innophos-holdings-inc-iphs.html.

About Innophos Holdings

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Institutional Ownership by Quarter for Innophos Holdings (NASDAQ:IPHS)

Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.